Abstract:Androgenetic alopecia affects both men and women. In men it produces male pattern hair loss with bitemporal recession and vertex baldness. In women it produces female pattern hair loss (FPHL) with diffuse alopecia over the mid-frontal scalp. FPHL occurs as a result of nonuniform hair follicle miniaturization within follicular units. Diffuse alopecia is produced by a reduction in the number of terminal fibres per follicular unit. Baldness occurs only when all hairs within the follicular units are miniaturized and is a relatively late event in women. The concepts of follicular units and primary and secondary hair follicles within follicular units are well established in comparative mammalian studies, particularly in sheep. However, discovery of these structures in the human scalp hair and investigation of the changes in follicular unit anatomy during the development of androgenetic alopecia have provided a clearer understanding of the early stages of androgenetic alopecia and how the male and female patterns of hair loss are related. FPHL is the most common cause of alopecia in women and approximately one-third of adult caucasian women experience hair loss. The impact of FPHL is predominantly psychological. While men anticipate age-related hair loss, hair loss in women is usually unexpected and unwelcome at any age. Treatment options to arrest hair loss progression and stimulate partial hair regrowth for FPHL include the androgen receptor antagonists spironolactone and cyproterone acetate, the 5α-reductase inhibitor finasteride and the androgen-independent hair growth stimulator minoxidil. These treatments appear to work best when initiated early. Hair transplantation should be considered in advanced FPHL that is resistant to medical treatments. Hair transplantation requires well-preserved hair growth over the occipital donor area. The psychological impact of FPHL may also be reduced by cosmetic products that improve the appearance of the hair. These agents work to minimize hair fibre breakage, improve hair volume or conceal visible bald scalp.

The Diagnosis and Treatment of Hair and Scalp Diseases

Hair Loss: Diagnosis and Treatment

Diagnosing and treating hair loss

Alopecia areata. Pathogenesis, diagnosis, and therapy

Types and Treatment of Hair Loss in Men and Women

Diseases of the Hair and Scalp

Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness

A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents

Systematic approach to hair loss in women

The Hormonal Background of Hair Loss in Non-Scarring Alopecias

[Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors : Pathogenesis, clinical picture, diagnostics and prophylaxis]

Telogen Effluvium : Is There a Need for a New Classification ?

Telogen Effluvium: A Review of the Literature

Common causes of hair loss – clinical manifestations, trichoscopy and therapy

[Androgenetic alopecia: where do we stand in 2024?]

A review of the treatment of male pattern hair loss

Hair Cosmetics for the Hair Loss Patient

Hair loss in elderly women

The difficult hair loss patient: A particular challenge

Scarring Alopecia

Female Adolescent Hair Disorders